European capnography devices market was valued at $171.0 million in 2025 and is projected to reach $304.0 million by 2035, growing at a CAGR of 6.0% during the forecast period (2026–2035). Capnography devices are critical respiratory monitoring tools used to measure end-tidal carbon dioxide (EtCO?), supporting real-time assessment of ventilation, airway integrity, and metabolic status. These systems are widely deployed across operating rooms, intensive care units (ICUs), emergency departments, procedural sedation settings, and pre-hospital care environments. Market growth is being driven by the rising prevalence of respiratory disorders, increasing surgical and anesthesia procedures, and the growing emphasis on patient safety and continuous respiratory monitoring across European healthcare systems. Additionally, the expanding elderly population, higher incidence of chronic conditions such as COPD and sleep apnea, and stricter clinical guidelines mandating capnography use during sedation and critical care are accelerating adoption. Technological advancements including portable and handheld capnographs, integrated multiparameter monitors, and enhanced waveform analysis—are further improving clinical outcomes and workflow efficiency.

European air taxi market was valued at $87.2 million in 2025 and is projected to reach $508.1 million by 2035, growing at a CAGR of 19.3% during the forecast period (2026–2035). Air taxis, part of the emerging urban air mobility (UAM) sector, are designed to provide on-demand, short-distance aerial transportation, leveraging electric vertical takeoff and landing (eVTOL) aircraft to reduce travel time and alleviate urban congestion. The market is witnessing rapid growth across Europe, driven by increasing urbanization, traffic congestion in major cities, and growing investments in smart transportation infrastructure. Supportive government regulations, urban air mobility initiatives, and sustainability-focused policies are encouraging adoption of air taxi services. Key markets such as Germany, France, the United Kingdom, and the Netherlands are at the forefront of testing and deploying these advanced aerial mobility solutions.

European cell counting market was valued at $512.7 million in 2025 and is projected to reach $905.4 million by 2035, growing at a CAGR of 5.9% during the forecast period (2026–2035).  Rising healthcare investment across Europe is strengthening diagnostic infrastructure and accelerating demand for cell counting services, particularly in oncology and pathology. Increased funding is enabling the adoption of scalable laboratory models that improve turnaround times, standardization, and access to high-quality diagnostics across national healthcare systems. Major diagnostic service providers are actively expanding their footprints across Europe through cross-border laboratory setups, acquisitions, and capacity expansion to address growing test volumes.

Asia-Pacific cell counting market was valued at $470.8 million in 2025 and is projected to reach $899.7 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026–2035). The growth of biotechnology and pharmaceutical research and development in the Asia-Pacific region is significantly influencing the demand for cell counting solutions. Countries such as China, India, Japan, and South Korea are expanding their R&D capabilities, driven by increasing investment in drug discovery, development, and clinical research. Accurate and efficient cell counting is critical for applications ranging from quality control to experimental reproducibility in laboratory workflows. As pharmaceutical and biotech organizations scale their operations, the adoption of advanced cell counting technologies supports high-throughput analysis and data reliability. This trend reflects the broader modernization of laboratory infrastructure and the region’s focus on enhancing research productivity and innovation.

Asia-Pacific air taxi market was valued at $103.8 million in 2025 and is projected to reach $643.9 million by 2035, growing at a CAGR of 20.1% during the forecast period (2026–2035). Air taxis, primarily based on electric vertical takeoff and landing (eVTOL) aircraft, are designed to provide on-demand, short-distance urban and regional air mobility, offering a faster and more sustainable alternative to traditional ground transportation. The market is experiencing rapid growth across the Asia-Pacific region, driven by increasing urbanization, severe traffic congestion in major metropolitan areas, and strong government and private-sector investments in advanced air mobility (AAM). Countries such as China, Japan, South Korea, Singapore, Australia, and India are actively developing regulatory frameworks, pilot projects, and infrastructure to support the commercialization of air taxi services.

Asia-Pacific capnography devices market was valued at $156.7 million in 2025 and is projected to reach $300.4 million by 2035, growing at a CAGR of 6.8% during the forecast period (2026–2035). Capnography devices, which monitor the concentration of carbon dioxide in patients’ exhaled breath to assess respiratory status, are increasingly adopted across hospitals, surgical centers, and critical care units. The market growth is driven by rising demand for continuous patient monitoring, increasing prevalence of respiratory diseases, growing awareness of patient safety protocols, and adoption of advanced anesthesia and critical care technologies. Key trends shaping the market include the integration of wireless monitoring, portable and wearable capnography devices, AI-assisted respiratory analytics, and interoperability with hospital information systems to enhance patient care efficiency.

US rooftop solar panel market reached a value of $7.0 billion in 2025 and is expected to expand to $13.3 billion by 2035, recording a compound annual growth rate of 6.6% over the 2026–2035 forecast period. Rooftop solar adoption is emerging as a key growth driver for the US rooftop solar panel market as households and businesses increasingly turn to on-site electricity generation. Rooftop photovoltaic systems allow end users to reduce dependence on centralized power generation while benefiting from localized energy production. This shift toward rooftop and other behind-the-meter solar installations reflects growing consumer participation in the energy system and is strengthening the role of rooftop solar as a core component of distributed generation across multiple states.

UK rooftop solar panel market is estimated at $1.14 billion in 2025 and is expected to expand to $2.14 billion by 2035, registering a CAGR of 6.5% over the 2026–2035 forecast period. Rooftop solar in the UK is gathering pace as both homeowners and small businesses embrace solar PV for energy savings and cleaner power. Growth is supported by revised building regulations promoting energy efficiency on new builds, rising consumer confidence in solar technology, and increased awareness of cost advantages. These factors are driving sustained deployment of rooftop systems, contributing to a broader distributed energy strategy and reinforcing solar’s role in the UK’s clean energy transition.

North America rooftop solar panel market reached a valuation of $8.8 billion in 2025 and is forecast to expand to $16.2 billion by 2035, reflecting a CAGR of 6.4% across the 2026–2035 period. Rooftop solar and distributed installations are driving the transformation of the US energy landscape, enabling households and communities to generate their own power and reduce dependence on traditional grid sources. Residential rooftop systems now dominate the nation’s solar footprint, showcasing how behind-the-meter generation supports energy resilience and cost savings for millions of Americans. These installations strengthen local control over energy use, contribute to decarbonization targets, and have become essential to broader adoption of renewable energy across the region

North America laser projection market stood at $5.9 billion in 2025 and is expected to expand to $11.2 billion by 2035, reflecting a CAGR of 6.6% over the 2026 to 2035 forecast period. North America’s laser projection market is being driven by a structural upgrade cycle within the cinema exhibition industry, as major operators move beyond first-generation digital systems toward higher-performance, lower-cost-of-ownership projection technologies. Laser projection is increasingly positioned as the preferred replacement for lamp-based digital projectors due to its superior image quality, extended lifespan, reduced maintenance needs, and lower energy consumption. As exhibitors pursue premium presentation formats and operational efficiency at scale, laser projection has become a core component of long-term capital expenditure strategies across the region.